Alnylam Pharmaceuticals
ALNY
#630
Rank
ยฃ25.83 B
Marketcap
ยฃ200.29
Share price
-1.16%
Change (1 day)
38.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: ยฃ25.83 Billion

As of January 2025 Alnylam Pharmaceuticals has a market cap of ยฃ25.83 Billion. This makes Alnylam Pharmaceuticals the world's 630th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ25.83 B5.62%
2024ยฃ24.45 B29.72%
2023ยฃ18.85 B-21.98%
2022ยฃ24.16 B60.84%
2021ยฃ15.02 B35.63%
2020ยฃ11.07 B12.43%
2019ยฃ9.85 B69.55%
2018ยฃ5.81 B-37.66%
2017ยฃ9.32 B258.04%
2016ยฃ2.60 B-51.83%
2015ยฃ5.40 B12.38%
2014ยฃ4.80 B93.58%
2013ยฃ2.48 B319.24%
2012ยฃ0.59 B164.54%
2011ยฃ0.22 B-17.16%
2010ยฃ0.27 B-40.63%
2009ยฃ0.45 B-34.81%
2008ยฃ0.69 B17.08%
2007ยฃ0.59 B47.44%
2006ยฃ0.40 B170.95%
2005ยฃ0.14 B99.11%
2004ยฃ75.03 M

End of Day market cap according to different sources

On Jan 20th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

ยฃ25.83 Billion
by Yahoo Finance info icon info icon
ยฃ25.83 Billion
by CompaniesMarketCap info icon info icon
ยฃ25.83 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ1.97 B-92.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.91 B 135.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.16 B-64.52%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.80 B-96.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ66.05 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ158.61 B 513.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ103.46 B 300.50%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ20.19 B-21.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel